BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer.
$3.39-3.42%
报价 2026-11-13
市值
$29.6M
EV
$24.6M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -73.2%
$2.74$12.64
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BCTXBriaCell Therapeutics Corp. | $29.6M | -3.4% | – | 0% | – | – | – | |
| NNVCNanoViricides, Inc. | $31.4M | -8.9% | +133.3% | 0% | – | – | – | |
| PMNProMIS Neurosciences, Inc. | $29.6M | -5.5% | – | 0% | – | – | – | |
| GRCEGrace Therapeutics, Inc. | $29.5M | -0.8% | +900.0% | 0% | – | – | – | |
| NXTCNextCure, Inc. | $29.3M | +2.7% | -85.2% | 0% | – | – | – | |
| PTHSPelthos Therapeutics Inc. | $29.2M | -7.3% | +283.7% | 54.7% | – | – | – | |
| AARDAardvark Therapeutics, Inc. Common Stock | $29.1M | -12.5% | – | 0% | – | – | – | |
| NMADNOMAD Power Solutions, Inc. | $29M | -36.5% | – | 0% | – | – | – | |
| ELTXElicio Therapeutics, Inc. | $28.6M | -3.8% | +769.6% | 0% | – | – | – | |
| 同行中位数 | – | – | +283.7% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。